Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance

Código QR

Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance

Guardado en:

Detalles Bibliográficos
Autores principales:	Chenchen Feng, Yuqing Li, Kunping Li, Yinfeng Lyu, Wenhui Zhu, Haowen Jiang, Hui Wen
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/12528cec08354370842a3be2c54868f3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Sunitinib for advanced renal cell cancer
por: Chris Coppin
Publicado: (2008)

Two high-rate pentose-phosphate pathways in cancer cells
por: Vanessa Cossu, et al.
Publicado: (2020)

Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma.
por: Stephan Ursprung, et al.
Publicado: (2021)

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma
por: Jacob W. Greenberg, et al.
Publicado: (2021)

Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma
por: Stephan Ursprung, et al.
Publicado: (2021)

Metabolomics Analysis Discovers Estrogen Altering Cell Proliferation via the Pentose Phosphate Pathway in Infertility Patient Endometria
por: Yingxin Zheng, et al.
Publicado: (2021)

Gut Microbiota and Sunitinib-Induced Diarrhea in Metastatic Renal Cell Carcinoma: A Pilot Study
por: Su Z, et al.
Publicado: (2021)

Immune classification of clear cell renal cell carcinoma
por: Sumeyye Su, et al.
Publicado: (2021)

Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway
por: Xiaoyu Ma, et al.
Publicado: (2017)

[73] Outcomes of patients with advanced clear-cell renal cell carcinoma treated by sunitinib as first-line therapy: A prospective observational study in real-world practice of the Academic Hospital of Oran, Algeria
por: Nadia Ameziane, et al.
Publicado: (2018)

Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells
por: Dolman MEM, et al.
Publicado: (2012)

The Entner-Doudoroff and Nonoxidative Pentose Phosphate Pathways Bypass Glycolysis and the Oxidative Pentose Phosphate Pathway in <named-content content-type="genus-species">Ralstonia solanacearum</named-content>
por: Poonam Jyoti, et al.
Publicado: (2020)

The pentose phosphate pathway constitutes a major metabolic hub in pathogenic Francisella.
por: Héloise Rytter, et al.
Publicado: (2021)

Clonal architectures predict clinical outcome in clear cell renal cell carcinoma
por: Yi Huang, et al.
Publicado: (2019)

Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
por: Qingjian Li, et al.
Publicado: (2020)

Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib
por: Chris Coppin
Publicado: (2010)

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
por: Myung-Chul Kim, et al.
Publicado: (2021)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Wen-Bo Yang, et al.
Publicado: (2021)

EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
por: Mototaka Sato, et al.
Publicado: (2013)

Radiomics models based on enhanced computed tomography to distinguish clear cell from non-clear cell renal cell carcinomas
por: Ping Wang, et al.
Publicado: (2021)

Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
por: Nicholas Borcherding, et al.
Publicado: (2021)

The Potential of Visceral Adipose Tissue in Distinguishing Clear Cell Renal Cell Carcinoma from Renal Angiomyolipoma with Minimal Fat
por: Liu J, et al.
Publicado: (2021)

Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report
por: Sophie Ferlicot, et al.
Publicado: (2021)

Reconstruction of kidney renal clear cell carcinoma evolution across pathological stages
por: Shichao Pang, et al.
Publicado: (2018)

Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma
por: Bin Zheng, et al.
Publicado: (2021)

Publisher Correction: Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: U-Syn Ha, et al.
Publicado: (2018)

Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
por: Wen Li, et al.
Publicado: (2021)

Development of an Interferon Gamma Response-Related Signature for Prediction of Survival in Clear Cell Renal Cell Carcinoma
por: Liu L, et al.
Publicado: (2021)

Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus
por: Xiang-Ming Wang, et al.
Publicado: (2020)

RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression
por: Lei Wang, et al.
Publicado: (2021)

Antiangiogenic Properties of Axitinib versus Sorafenib Following Sunitinib Resistance in Human Endothelial Cells—A View towards Second Line Renal Cell Carcinoma Treatment
por: Eva Juengel, et al.
Publicado: (2021)

VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2
por: Yao-Hui Gao, et al.
Publicado: (2017)

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma
por: Xiaona Wei, et al.
Publicado: (2017)

Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro
por: Jiang H, et al.
Publicado: (2021)

Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells
por: Guoxi Zhang, et al.
Publicado: (2021)

Itaconic acid exerts anti-inflammatory and antibacterial effects via promoting pentose phosphate pathway to produce ROS
por: Xiaoyang Zhu, et al.
Publicado: (2021)

Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade
por: Chisato Ohe, et al.
Publicado: (2021)

Systematic expression analysis of m6A RNA methyltransferases in clear cell renal cell carcinoma
por: Larissa Gundert, et al.
Publicado: (2021)

Diagnostic and prognostic value of placental growth factor serum concentration in clear cell renal cell carcinoma
por: Marcela Cechova, et al.
Publicado: (2021)

VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
por: Athina Ganner, et al.
Publicado: (2021)